Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × apremilast × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 1 Pruritus 1 Lymphoma, Follicular 1

Interventions

pembrolizumab 849 Carboplatin 791 Paclitaxel 779 Gemcitabine 650 Cisplatin 627 Docetaxel 600 Bevacizumab 521 Nivolumab 420 Pemetrexed 410 Cyclophosphamide 396 Capecitabine 386 Fluorouracil 333 Dexamethasone 329 Rituximab 328 Oxaliplatin 284 Injections 280 atezolizumab 262 Trastuzumab 257 Cetuximab 237 Leucovorin 227 Irinotecan 216 Prednisone 215 130-nm albumin-bound paclitaxel 214 Doxorubicin 209 Ipilimumab 199 Lenalidomide 193 Fulvestrant 186 fludarabine 177 durvalumab 174 venetoclax 168

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03721172 2024-05-29

ADVANCE

Amgen

Phase 3 Completed

595 enrolled 19 charts

Lymphoma, Follicular, Pruritus, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡